Skip to main content
Fig. 1 | Radiation Oncology

Fig. 1

From: High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study

Fig. 1

CONSORT diagram. In total, 144 patients with stage I and II NSCLC were treated with SBRT using a CyberKnife® from August 2010 to June 2019. Patients with stage II disease or central lung cancer and those who had serious comorbidities or active double cancer were excluded from the study. Finally, 96 patients with stage I peripheral NSCLC were analyzed in the current study. Abbreviations: NSCLC, non-small cell lung cancer; SBRT, stereotactic body radiotherapy

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us